URL | https://www.bullrunnow.com/news/article/18.5_milli |
Source | Bull Run Now |
Date Published | 07/19/2024 |
Company/Division name | Capra Biosciences |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Year reshoring announced: | 2024 |
Domestically, the work will be done: | In-house |
Capital investment ($): | 7.5 |
State(s) reshored to: | VA |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | active pharmaceutical ingredients |
What domestic positive factors made reshoring more attractive? | Government Incentives |